Philips launches high-field MR
The Intera Enterprise, a 1.5T scanner, has risen to the upper end of MR offerings at Philips Medical Systems. The new product, currently available only in the U.S., is being marketed primarily to privately owned imaging centers, according to the company.
The Intera Enterprise, a 1.5T scanner, has risen to the upper end of MR offerings at Philips Medical Systems. The new product, currently available only in the U.S., is being marketed primarily to privately owned imaging centers, according to the company. The short-bore Intera Enterprise, announced July 24, also comes in a mobile configuration. Philips executives view the entrepreneurial marketplace as an opportunity for growth. They claim a 30% share in MR sales to this U.S. market segment. The four-channel radio-frequency system supports optimized packages for neuro, orthopedic, body, cardiac, and vascular applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
What if Radiology Turns Out Exactly the Way We Predict it Will?
May 19th 2025Whether it is reimbursement cuts or continued attempts to push non-radiologist image interpretation, where do we draw the line between inspired protest and misspent energy criticizing things that are doomed to fail or things we have no control over?
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
May 16th 2025For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.
